1J5 — Hyphens Pharma International Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual income statement for Hyphens Pharma International, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

	C2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	121	126	162	171	195
Cost of Revenue
Gross Profit	43.6	48.1	62.8	61.9	69.5
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	113	117	147	158	181
Operating Profit	7.65	9.03	15.6	12.3	14.7
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.11	8.26	14.3	10.6	13
Provision for Income Taxes
Net Income After Taxes	6.16	6.85	11.4	8.58	10.9
Minority Interest
Net Income Before Extraordinary Items
Net Income	6.16	6.85	11.4	8.57	10.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	6.16	6.85	11.4	8.57	10.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.019	0.021	0.035	0.028	0.034
Dividends per Share
Special Dividends per Share